Detalles de la búsqueda
1.
Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
J Clin Oncol
; 21(9): 1746-51, 2003 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12721250
2.
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 16(3): 200-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25516338
3.
Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
J Thorac Oncol
; 10(2): 353-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25611228
4.
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.
Clin Cancer Res
; 19(1): 258-67, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23082002
5.
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.
Clin Cancer Res
; 19(10): 2745-54, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23444220
6.
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
J Clin Oncol
; 31(34): 4349-57, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24145346
7.
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.
J Clin Oncol
; 29(33): 4394-400, 2011 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21969495
8.
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.
J Clin Oncol
; 28(6): 918-27, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100958
9.
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.
J Clin Oncol
; 28(6): 911-7, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100966
10.
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
J Natl Cancer Inst
; 96(20): 1557-9, 2004 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15494606
Resultados
1 -
10
de 10
1
Próxima >
>>